SLC7A5 and bladder transitional cell carcinoma: Additionally, chemotherapy drugs were more sensitive to patients with high SLC7A5 levels (Fig. 6D-E) Based on the results presented here, SLC7A5 may be a potential predictor of the efficacy of ICB in BLCA and may be an indicator of the effectiveness of treatment for BLCA.